Brief: Quince Therapeutics Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing
Dec 18 (Reuters) - Quince Therapeutics Inc QNCX.O :
* QUINCE THERAPEUTICS: FILES FOR MIXED SHELF OFFERING OF UP
TO
$200 MILLION - SEC FILING
* QUINCE THERAPEUTICS: SALES AGREEMENT PROSPECTUS COVERS
OFFERING
OF UP TO $75.0 MILLION OF COMMON STOCK THAT MAY BE ISSUED FROM
TIME TO TIME
Source text: ID:n0001628280-24-051856
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges